coenzyme Q10

A European trial in Friedreich’s ataxia finds that combining two experimental therapies improves heart health and neurological function

posted on October 20, 2010 - 11:31am
Results from a clinical trial conducted in Spain involving 20 individuals with Friedreich's ataxia (FA) show that a combination therapy using two drugs, idebenone and deferiprone (DFP), demonstrated a "stabilizing effect" in neurological function and reduced abnormal heart-muscle enlargement in participants who received the two-drug combo for a period of 11 months.

A European trial in Friedreich’s ataxia finds that combining two experimental therapies improves heart health and neurological function

posted on October 20, 2010 - 11:31am
Results from a clinical trial conducted in Spain involving 20 individuals with Friedreich's ataxia (FA) show that a combination therapy using two drugs, idebenone and deferiprone (DFP), demonstrated a "stabilizing effect" in neurological function and reduced abnormal heart-muscle enlargement in participants who received the two-drug combo for a period of 11 months.